These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9161471)

  • 1. Risk of malignant transformation in patients with monoclonal gammopathy of undetermined significance.
    Pasqualetti P; Casale R
    Biomed Pharmacother; 1997; 51(2):74-8. PubMed ID: 9161471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The natural history of monoclonal gammopathy of undetermined significance. A 5- to 20-year follow-up of 263 cases.
    Pasqualetti P; Festuccia V; Collacciani A; Casale R
    Acta Haematol; 1997; 97(3):174-9. PubMed ID: 9066713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant transformation and life expectancy in monoclonal gammopathy of undetermined significance.
    Blade J; Lopez-Guillermo A; Rozman C; Cervantes F; Salgado C; Aguilar JL; Vives-Corrons JL; Montserrat E
    Br J Haematol; 1992 Jul; 81(3):391-4. PubMed ID: 1390212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of different hematologic variables in defining the risk of malignant transformation in monoclonal gammopathy.
    Baldini L; Guffanti A; Cesana BM; Colombi M; Chiorboli O; Damilano I; Maiolo AT
    Blood; 1996 Feb; 87(3):912-8. PubMed ID: 8562962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Cesana C; Klersy C; Barbarano L; Nosari AM; Crugnola M; Pungolino E; Gargantini L; Granata S; Valentini M; Morra E
    J Clin Oncol; 2002 Mar; 20(6):1625-34. PubMed ID: 11896113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant transformation in IgM monoclonal gammopathy of undetermined significance.
    Montoto S; Rozman M; Rosiñol L; Nadal E; Giné E; Aymerich M; Ferrer A; Esteve J; Bosch F; López-Guillermo A; Bladé J; Montserrat E
    Semin Oncol; 2003 Apr; 30(2):178-81. PubMed ID: 12720132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant transformation of monoclonal gammopathy of undetermined significance among out-patients of a community hospital in southeastern Netherlands.
    van de Poel MH; Coebergh JW; Hillen HF
    Br J Haematol; 1995 Sep; 91(1):121-5. PubMed ID: 7577618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Monoclonal gammopathy of undetermined significance and asymptomatic multiple myelom in the year 2014 ].
    Adam Z; Krejčí M; Pour L; Sevčíková E; Křivanová A; Rehák Z; Koukalová R; Cermáková Z; Vaníček J; Sevčíková S
    Vnitr Lek; 2014 Oct; 60(10):861-79. PubMed ID: 25382009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal gammopathy of undetermined significance.
    Kyle RA
    Blood Rev; 1994 Sep; 8(3):135-41. PubMed ID: 7819815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal Gammopathy of Undetermined Significance (MGUS)Monoclonal Gammopathy of Undetermined Significance (MGUS).
    Viera S; Ludek P; Zdeněk A; Marta K; Martin Š; Sabina Š; Zdeněk K
    Klin Onkol; 2018; 31(4):270-276. PubMed ID: 30541309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of M-component type and immunoglobulin concentration on the risk of malignant transformation in patients with monoclonal gammopathy of undetermined significance.
    Gregersen H; Mellemkjaer L; Ibsen JS; Dahlerup JF; Thomassen L; Sørensen HT
    Haematologica; 2001 Nov; 86(11):1172-9. PubMed ID: 11694403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant transformation of monoclonal gammopathy of undetermined significance: cumulative incidence and prognostic factors.
    Van De Donk N; De Weerdt O; Eurelings M; Bloem A; Lokhorst H
    Leuk Lymphoma; 2001 Aug; 42(4):609-18. PubMed ID: 11697489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Follow-up of monoclonal gammopathy of undetermined significance in a population of 51 patients older than 70 years ].
    Decaux O; Cazalets-Lacoste C; Cador-Rousseau B; Laurat E; Sebillot M; Bracq J; Jego P; Leblay R; Grosbois B
    Rev Med Interne; 2002 Sep; 23(9):751-8. PubMed ID: 12378828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood clonal B-cell excess in patients with monoclonal gammopathy of undetermined significance (MGUS): association with malignant transformation.
    Isaksson E; Björkholm M; Holm G; Johansson B; Nilsson B; Mellstedt H; Osterborg A
    Br J Haematol; 1996 Jan; 92(1):71-6. PubMed ID: 8562414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A series of 618 cases of monoclonal gammopathies of undetermined significance: predictive factors of disappearance of monoclonal component or evolution to malignant gammopathies].
    González García ME; Fernández Alvarez C; Robles Marinas V; González Huerta AJ; Arias Miranda MI; González Rodríguez AP; García Casas J; de La Tassa JM; Fernández García J
    Rev Clin Esp; 2008 Jun; 208(6):288-94. PubMed ID: 18620653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of IgM monoclonal gammopathy of undetermined significance.
    Kyle RA; Therneau TM; Rajkumar SV; Remstein ED; Offord JR; Larson DR; Plevak MF; Melton LJ
    Blood; 2003 Nov; 102(10):3759-64. PubMed ID: 12881316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Malignant transformation of monoclonal gammopathy of undetermined significance].
    Decaux O; Avet-Loiseau H; Grosbois B
    Presse Med; 2007 Dec; 36(12 Pt 3):1985-96. PubMed ID: 17509811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal gammopathy of undetermined significance and solitary plasmacytoma. Implications for progression to overt multiple myeloma.
    Kyle RA
    Hematol Oncol Clin North Am; 1997 Feb; 11(1):71-87. PubMed ID: 9081205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A long-term study of prognosis in monoclonal gammopathy of undetermined significance.
    Kyle RA; Therneau TM; Rajkumar SV; Offord JR; Larson DR; Plevak MF; Melton LJ
    N Engl J Med; 2002 Feb; 346(8):564-9. PubMed ID: 11856795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal gammopathy of undetermined significance.
    Kyle RA; Rajkumar SV
    Clin Lymphoma Myeloma; 2005 Sep; 6(2):102-14. PubMed ID: 16231848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.